Brief: Newbury Signs Licence And Supply Deal For Guanfacine
17/08/2026 14:21
BRIEF-Newbury Signs Licence And Supply Deal For Guanfacine Aug 17 (Reuters) - Newbury Pharmaceuticals AB NEWBRY.ST:
SIGNS LICENCE AND SUPPLY AGREEMENT TO LAUNCH GUANFACINE IN SWEDEN
Source text: ID:nMFN7grFK6
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln